With over 30 years of experience in public relations, Eliza is a trusted media relations strategist specializing in life sciences, healthcare public relations, and crisis management. Her expertise spans the full spectrum of biotech and pharmaceutical media relations, from guiding startups (including through IPOs) to supporting commercial-stage biopharma and big pharma companies.

Eliza has a proven track record of crafting and executing strategic media relations campaigns across diverse therapeutic areas and business verticals. Her skill set includes corporate awareness, c-suite communications, science-driven storytelling, financial communications, issues management, and regulatory milestone announcements. Leveraging an extensive network of media contacts, she excels at generating impactful coverage that enhances brand reputation and visibility.

Throughout her career, Eliza has successfully supported leading companies such as:

Biotech: Allyx, Akari, Akebia, Amarin, Amgen, Arvinas, Aveo Oncology, Celgene, Corbus, Currax, EIP Pharma, Enzyvant, Epizyme, Gemnab, Jazz, Kadmon, Karyopharm, Mattinas, Merz, Milestone, Neurogastrix, Palatin, Ra Pharma, Shire, Sunovion, Syndax, Telix, Verastem, Xilio

Pharmaceutical: Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Organon, Purdue, Eisai, Takeda

MedTech/Device: Intuitive Surgical, ReShape, ZimVie, Sequel Med Tech, DEKA Research & Development Corp., Medtronic

Passionate about bringing groundbreaking treatments to market, Eliza partners with her clients to deliver exceptional results, no matter the challenge.

Before launching her consulting practice, she honed her expertise at top PR agencies, including Ogilvy, GCI, and Ruder Finn.